Loading clinical trials...
Loading clinical trials...
The early evaluation of AP severity are vital. Previous studies have shown non-alcoholic fatty liver disease (NAFLD) is associated with severity of acute pancreatitis (AP). This study is aimed to inve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ningbo No. 1 Hospital
NCT05330923 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and more
NCT04195347 · Acute Pancreatitis
NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT07450898 · Acute Pancreatitis (AP), Thrombotic Disorders
Ningbo NO.1 hospital
Ningbo, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions